陶氏病
调节器
细胞生物学
突变体
神经科学
内生
生物
τ蛋白
疾病
神经突
化学
病态的
神经退行性变
小RNA
HEK 293细胞
蛋白质聚集
中枢神经系统
人脑
负调节器
人类疾病
过程(计算)
磷酸化
核糖核酸
作者
Ami Kobayashi,Chung-Ta Han,Lien Nguyen,Karen Tsay,M Martins,Prakash Kharel,Yanhong Zhang,M. Inmaculada Barrasa,Allison M. Williams,Nana Kunii,Yasutoshi Akiyama,Vikram Khurana,Bradley T. Hyman,Pavel Ivanov,Songi Han,Anna M. Krichevsky
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-05-18
被引量:1
标识
DOI:10.64898/2026.05.17.725757
摘要
Summary Tauopathies, including Alzheimer’s disease (AD), are driven by pathological Tau aggregation, a process that requires co-factors. Small RNAs (sRNA) have been proposed as such co-factors, yet little is known about endogenous transcripts that promote Tau pathology. We identify stress-induced tRNA-derived RNAs or fragments (tDRs/tRFs) as the most dysregulated sRNA class in human AD brains, PS19 mice overexpressing mutant human Tau, and human neuronal tauopathy models. Notably, the highly accumulating 5’Glu CTC and 5’Gly GCC tRFs directly bind Tau and induce its phosphorylation, oligomerization, fibril formation, and impact neurite growth. 5’Glu CTC is enriched in pathological Tau precipitates and co-localizes with oligomeric Tau in PS19 mouse brains. Inhibiting 5’Glu CTC mitigates Tau pathology. Furthermore, these tRFs are highly secreted by neurons and can be taken up by recipient cells, contributing to Tau pathology. Our findings establish 5’Glu CTC as a key regulator of Tau aggregation and suggest its inhibition as a promising therapeutic strategy for tauopathies. Highlights Specific stress-induced 5’tRFs strongly accumulate in Alzheimer’s disease brains 5’Glu CTC binds and co-localizes with pathologic Tau in neurons and in the brain 5’Glu CTC promotes pathologic Tau species while its inhibition reverses these effects Specific 5’tRFs are horizontally transferred between neurons
科研通智能强力驱动
Strongly Powered by AbleSci AI